Retour
Fourchette du Jour
13,11 €
13,49 €
Fourchette 52 Semaines
6,85 €
16,47 €
Volume
7 650 568
Moyenne 50J / 200J
14,22 €
/
11,17 €
Clôture Précédente
13,29 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,4 | 0,4 |
| P/B | 1,1 | 2,9 |
| ROE % | -21,1 | 3,7 |
| Net Margin % | -24,6 | 3,9 |
| Rev Growth 5Y % | -5,4 | 10,0 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Hold
15,25 €
+14.1%
Low: 12,00 €
High: 18,00 €
P/E Prévisionnel
5,4
BPA Prévisionnel
2,45 €
Croissance BPA (est.)
+0,0%
CA Est.
15 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,00 €
0,00 € – 0,00 €
|
15 B | 0 |
| FY2028 |
3,25 €
1,49 € – 5,02 €
|
15 B | 2 |
| FY2027 |
2,67 €
2,36 € – 2,77 €
|
15 B | 5 |
Points Clés
Revenue declined -5,44% annually over 5 years
Generating 1,94B in free cash flow
Capital efficient — spends only 2,65% of revenue on capex
Croissance
Revenue Growth (5Y)
-5,44%
Revenue (1Y)-2,98%
Earnings (1Y)N/A
FCF Growth (3Y)-8,72%
Qualité
Return on Equity
-21,08%
ROIC-6,79%
Net Margin-24,58%
Op. Margin-18,62%
Sécurité
Debt / Equity
1,00
Current Ratio1,30
Interest Coverage-5,65
Valorisation
P/E Ratio
-4,38
P/B Ratio1,05
EV/EBITDAN/A
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2,98% | Revenue Growth (3Y) | -3,72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -5,44% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14,30B | Net Income (TTM) | -3,51B |
| ROE | -21,08% | ROA | -9,45% |
| Gross Margin | 35,06% | Operating Margin | -18,62% |
| Net Margin | -24,58% | Free Cash Flow (TTM) | 1,94B |
| ROIC | -6,79% | FCF Growth (3Y) | -8,72% |
| Safety | |||
| Debt / Equity | 1,00 | Current Ratio | 1,30 |
| Interest Coverage | -5,65 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | -4,38 | P/B Ratio | 1,05 |
| P/S Ratio | 1,08 | PEG Ratio | -0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,04% |
| Market Cap | 15,39B | Enterprise Value | 28,74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14,30B | 14,74B | 15,43B | 16,26B | 17,89B |
| Net Income | -3,51B | -634,20M | 54,70M | 2,08B | -1,27B |
| EPS (Diluted) | -3,00 | -0,53 | 0,05 | 1,71 | -1,05 |
| Gross Profit | 5,01B | 5,62B | 6,44B | 6,50B | 5,58B |
| Operating Income | -2,66B | 10,10M | 766,20M | 1,61B | -34,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 37,19B | 41,50B | 47,69B | 50,02B | 54,84B |
| Total Liabilities | 22,48B | 22,87B | 27,22B | 28,95B | 34,35B |
| Shareholders' Equity | 14,71B | 18,64B | 20,47B | 21,07B | 20,49B |
| Total Debt | 14,70B | 14,31B | 18,37B | 19,53B | 23,36B |
| Cash & Equivalents | 1,35B | 734,80M | 991,90M | 1,26B | 701,20M |
| Current Assets | 9,22B | 9,52B | 12,98B | 10,64B | 10,90B |
| Current Liabilities | 7,09B | 5,78B | 7,78B | 6,75B | 9,88B |